Triptorelin and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Triptorelin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can affect your heart's rhythm. Buprenorphine (a pain or opioid-dependence medicine) and triptorelin (used for prostate cancer, endometriosis, or other hormone-related conditions) can each slightly stretch out a part of your heartbeat called the QT interval. Taken together, that effect may add up, which in rare cases can lead to an irregular heartbeat.
This is a theoretical concern, meaning it is based on how the drugs work rather than lots of real-world reports. The good news is your care team can manage this by watching your heart, checking blood minerals like potassium and magnesium, and tailoring your treatment. Please don't stop either medicine on your own. Just talk with your pharmacist or doctor.
Effect: Additive QT-interval prolongation with concurrent buprenorphine and triptorelin. Neither drug is a prodrug; this is a pharmacodynamic (additive), not pharmacokinetic, interaction.
- Direction/magnitude: Additive QTc effect; magnitude of the combination is not established.
- Onset: Unspecified.
- Evidence: Theoretical; combined risk not quantified.
- Management: Where possible avoid concomitant use. If used together, obtain baseline and periodic ECGs, correct and monitor electrolytes (K+, Mg2+), and assess additional risk factors (bradycardia, CHF, congenital long-QT, recent cardioversion, digoxin therapy, baseline QT prolongation).
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Do not use buprenorphine together with medications capable of extending the QT interval342. It remains unknown what risk arises from pairing buprenorphine with other agents that prolong QT. When prescribing buprenorphine to patients who have risk factors, including hypokalemia, bradycardia, recent conversion from atrial fibrillation, congestive heart failure, digitalis therapy, baseline QT prolongation, subclinical long-QT syndrome, or severe hypomagnesemia, take these observations into account during clinical decision-making1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Because both can affect heart rhythm, your care team may take steps to keep you safe.
- Your team may check an ECG before and during treatment.
- They may check and correct blood minerals like potassium and magnesium.
- They may review other heart risk factors (slow heart rate, heart failure, recent heart-rhythm procedures, or a personal or family history of long-QT).
- In some cases they may choose an alternative or individualize your treatment.
Tell your pharmacist or doctor if you feel fainting, palpitations, or dizziness.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Triptorelin and Buprenorphine together?
Combining buprenorphine and triptorelin may add up to a higher risk of QT-interval prolongation, so your care team may monitor your heart rhythm and electrolytes; keep taking both as prescribed and report any fainting or palpitations. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Triptorelin and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Triptorelin and Buprenorphine interaction managed?
Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Because both can affect heart rhythm, your care team may take steps to keep you safe. Your team may check an ECG before and during treatment. They may check and correct blood minerals like potassium and magnesium. They may review other heart risk factors (slow heart rate, heart failure, recent heart-rhythm procedu… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Triptorelin or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
- Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
- Product Information: BELBUCA(TM) buccal film, buprenorphine buccal film. Endo Pharmaceuticals Inc. (per FDA), Malvern, PA, 2016.
- Product Information: BUPRENEX(R) intravenous injection, intramuscular injection, buprenorphine HCl intravenous injection, intramuscular injection. Indivior Inc. (per DailyMed), Richmond, VA, 2016. DailyMed
Keep reading about Buprenorphine
Keep reading about Triptorelin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist